+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

aTyr Pharma Inc (LIFE) - Financial and Strategic SWOT Analysis Review

  • ID: 4285098
  • SWOT Analysis
  • 25 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

aTyr Pharma Inc (aTyr Pharma) is a biotherapeutics company that discovers and develops physiocrine-based therapies. The company’s resolaris is a potential intravenous protein therapeutic for the treatment of rare myopathies with an immune component. It offers phyisiocrine, which is a class of endogenous human proteins from amino acyl tRNA synthetases that function as extracellular signaling molecules in different physiologic settings. aTyr Pharma develops drugs for cancer, neurodegenerative diseases, inflammation, and metabolic disorders. The company collaborates with research institutions for its research and development activities. It has presence in the US and Hong Kong. aTyr Pharma is headquartered in San Diego, California, the US.

aTyr Pharma Inc Key Recent Developments

Nov 14, 2017: aTyr Pharma Announces Third Quarter 2017 Operating Results and Provides Corporate Update
Nov 03, 2017: aTyr promotes data expert Sanjay Shukla as CEO
Nov 01, 2017: aTyr Pharma Announces Leadership Transition
Aug 14, 2017: aTyr Pharma Announces Second Quarter 2017 Operating Results and Provides an Update on Innovative Immunology Pipeline
May 11, 2017: aTyr Pharma Announces First Quarter 2017 Operating Results

This comprehensive SWOT profile of aTyr Pharma Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of aTyr Pharma Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
2 of 3
Section 1 - About the Company
  • aTyr Pharma Inc - Key Information
  • aTyr Pharma Inc - Overview
  • aTyr Pharma Inc - Key Employees
  • aTyr Pharma Inc - Key Employee Biographies
  • aTyr Pharma Inc - Key Operational Heads
  • aTyr Pharma Inc - Major Products and Services
  • aTyr Pharma Inc - History
  • aTyr Pharma Inc - Company Statement
  • aTyr Pharma Inc - Locations And Subsidiaries
  • aTyr Pharma Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • aTyr Pharma Inc - Business Description
  • aTyr Pharma Inc - Corporate Strategy
  • aTyr Pharma Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • aTyr Pharma Inc - Strengths
  • aTyr Pharma Inc - Weaknesses
  • aTyr Pharma Inc - Opportunities
  • aTyr Pharma Inc - Threats
  • aTyr Pharma Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • aTyr Pharma Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • aTyr Pharma Inc, Key Information
  • aTyr Pharma Inc, Key Ratios
  • aTyr Pharma Inc, Share Data
  • aTyr Pharma Inc, Major Products and Services
  • aTyr Pharma Inc, History
  • aTyr Pharma Inc, Key Employees
  • aTyr Pharma Inc, Key Employee Biographies
  • aTyr Pharma Inc, Key Operational Heads
  • aTyr Pharma Inc, Other Locations
  • aTyr Pharma Inc, Subsidiaries
  • aTyr Pharma Inc, Key Manufacturing facilities
  • aTyr Pharma Inc, Key Competitors
  • aTyr Pharma Inc, SWOT Analysis
  • aTyr Pharma Inc, Ratios based on current share price
  • aTyr Pharma Inc, Annual Ratios
  • aTyr Pharma Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • aTyr Pharma Inc, Performance Chart
  • aTyr Pharma Inc, Ratio Charts
Note: Product cover images may vary from those shown
3 of 3


Order Online - visit: https://www.researchandmarkets.com/reports/4285098